Former Jaguars cheerleader's death from colorectal cancer highlights rising cases Since the mid-1990s, colorectal cancer cases among adults aged 20 to 39 have increased by about two percent each year.

Research led by Samsung Medical Center finds breast cancer survivors exhibit an 8% lower risk of Alzheimer's dementia (AD) compared with cancer-free individuals, with radiation therapy potentially ...

Colorectal cancer is the second-leading cause of cancer related death in the U.S., with nearly 53,0001 fatalities expected in 2025. While the burden of this disease is significant, advancements in ...

High dose radiation therapy may fuel cancer spread, UChicago study finds Scientists uncover surprising immune response that helps tumors grow, revealing new strategies to improve treatment ...

Exercise may significantly reduce the risk of colon cancer returning in patients after treatment, a phase 3 clinical trial finds.

A new study shows higher doses of radiation given over fewer sessions for breast cancer was as effective as being given lower doses over more sessions.

A new trial of patients with advanced rectal cancer has found that the addition of immunotherapy treatment alongside extended radiotherapy led to better rates of remission.

A new paradigm in rectal cancer treatment Together, these five studies demonstrate the transformative potential of radiotherapy as a curative and organ-preserving treatment.

Christopher Sadowski “Using the standard-of-care treatment of surgery, radiation, and chemotherapy to treat rectal cancer is effective,” Cercek said.

New research shows 92% of cancer patients stayed cancer-free for two years after immune-based therapy, potentially avoiding surgery and harsh treatments.

A "groundbreaking" cancer treatment trial by Memorial Sloan Kettering shows immunotherapy alone can eliminate some tumors, offering patients an alternative to chemotherapy and surgery.